by adminAdrianRamirez | Nov 10, 2016 | Press Releases
SAN DIEGO, CA — (Marketwired – October 19, 2016) – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that it has garnered national news coverage in major local and national TV...
by adminAdrianRamirez | Nov 9, 2016 | Press Releases
SAN DIEGO, CA–(Marketwired – November 09, 2016) – Medical Marijuana, Inc.(OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that it applauds the passage of medical marijuana provisions across the...
by adminAdrianRamirez | Nov 7, 2016 | Press Releases
CEO of First Publicly-Traded Cannabis Company in U.S. Discusses Company Strategy, Cannabis Industry Trends and Investment Opportunities SAN DIEGO, CA–(Marketwired – October 19, 2016) – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly...
by adminAdrianRamirez | Nov 3, 2016 | Axim Biotechnologies, Media Coverage, Press Releases
Cannabinoid Innovator’s Product Pipeline Highlights Timelines of Its Intellectual Property (IP) Protected Cannabinoid-Based Products from Pre-Clinical to NDA for Multiple Indications NEW YORK – Nov. 3, 2016 – Medical Marijuana, Inc. (OTC: MJNA) today announced that...
by adminAdrianRamirez | Nov 1, 2016 | Axim Biotechnologies, Press Releases
NEW YORK, NY –(Marketwired – November 01, 2016) – Medical Marijuana, Inc.(MJNA) today announced that its portfolio company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has begun pharmacokinetic/pharmacodynamics (PK/PD) studies with its CanChew...